IOL Chemicals and Pharmaceuticals Limited manufactures and sells bulk drugs, and organic and inorganic chemical compounds in India and internationally. More Details
Flawless balance sheet and good value.
Share Price & News
How has IOL Chemicals and Pharmaceuticals's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: IOLCP is more volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 9% a week.
Volatility Over Time: IOLCP's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
7 Day Return
1 Year Return
Return vs Industry: IOLCP exceeded the Indian Pharmaceuticals industry which returned 46.7% over the past year.
Return vs Market: IOLCP exceeded the Indian Market which returned 71.1% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is IOL Chemicals and Pharmaceuticals's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 weeks ago | Simply Wall StCan You Imagine How Elated IOL Chemicals and Pharmaceuticals' (NSE:IOLCP) Shareholders Feel About Its 585% Share Price Gain?
1 month ago | Simply Wall StIs IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP) An Attractive Dividend Stock?
1 month ago | Simply Wall StIs IOL Chemicals and Pharmaceuticals (NSE:IOLCP) Using Too Much Debt?
Is IOL Chemicals and Pharmaceuticals undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: IOLCP (₹565.45) is trading below our estimate of fair value (₹855.1)
Significantly Below Fair Value: IOLCP is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: IOLCP is good value based on its PE Ratio (7.3x) compared to the IN Pharmaceuticals industry average (19.6x).
PE vs Market: IOLCP is good value based on its PE Ratio (7.3x) compared to the Indian market (18.4x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate IOLCP's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: IOLCP is overvalued based on its PB Ratio (3.1x) compared to the IN Pharmaceuticals industry average (2.3x).
How is IOL Chemicals and Pharmaceuticals forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as IOL Chemicals and Pharmaceuticals has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has IOL Chemicals and Pharmaceuticals performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: IOLCP has high quality earnings.
Growing Profit Margin: IOLCP's current net profit margins (23.6%) are higher than last year (19.9%).
Past Earnings Growth Analysis
Earnings Trend: IOLCP has become profitable over the past 5 years, growing earnings by 69.7% per year.
Accelerating Growth: IOLCP's earnings growth over the past year (23.4%) is below its 5-year average (69.7% per year).
Earnings vs Industry: IOLCP earnings growth over the past year (23.4%) underperformed the Pharmaceuticals industry 39.9%.
Return on Equity
High ROE: IOLCP's Return on Equity (42%) is considered outstanding.
How is IOL Chemicals and Pharmaceuticals's financial position?
Financial Position Analysis
Short Term Liabilities: IOLCP's short term assets (₹9.1B) exceed its short term liabilities (₹3.0B).
Long Term Liabilities: IOLCP's short term assets (₹9.1B) exceed its long term liabilities (₹596.6M).
Debt to Equity History and Analysis
Debt Level: IOLCP's debt to equity ratio (2%) is considered satisfactory.
Reducing Debt: IOLCP's debt to equity ratio has reduced from 231.4% to 2% over the past 5 years.
Debt Coverage: IOLCP's debt is well covered by operating cash flow (1764.2%).
Interest Coverage: IOLCP earns more interest than it pays, so coverage of interest payments is not a concern.
What is IOL Chemicals and Pharmaceuticals's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: IOLCP's dividend (0.69%) is higher than the bottom 25% of dividend payers in the Indian market (0.43%).
High Dividend: IOLCP's dividend (0.69%) is low compared to the top 25% of dividend payers in the Indian market (1.9%).
Stability and Growth of Payments
Stable Dividend: Too early to tell whether IOLCP's dividend payments have been stable as they only just started paying a dividend.
Growing Dividend: Too early to tell if IOLCP's dividend payments are increasing as they only just started paying a dividend.
Current Payout to Shareholders
Dividend Coverage: With its low payout ratio (8.8%), IOLCP's dividend payments are thoroughly covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Varinder Gupta (58 yo)
Shri. Varinder Gupta has been Managing Director of IOL Chemicals and Pharmaceuticals Limited (also known as Industrial Organics Ltd.) since September 1, 2007 and was Chairman since November 14, 2018 until ...
CEO Compensation Analysis
Compensation vs Market: Varinder's total compensation ($USD676.30K) is above average for companies of similar size in the Indian market ($USD340.69K).
Compensation vs Earnings: Varinder's compensation has increased by more than 20% in the past year.
Experienced Management: IOLCP's management team is seasoned and experienced (5.7 years average tenure).
Experienced Board: IOLCP's board of directors are considered experienced (5.9 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: IOLCP insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.2%.
IOL Chemicals and Pharmaceuticals Limited's company bio, employee growth, exchange listings and data sources
- Name: IOL Chemicals and Pharmaceuticals Limited
- Ticker: IOLCP
- Exchange: NSEI
- Founded: 1986
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: ₹33.946b
- Shares outstanding: 58.71m
- Website: https://www.iolcp.com
Number of Employees
- IOL Chemicals and Pharmaceuticals Limited
- 85, Industrial Area 'A'
IOL Chemicals and Pharmaceuticals Limited manufactures and sells bulk drugs, and organic and inorganic chemical compounds in India and internationally. It operates through Chemicals and Drugs segments. The...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/04/19 12:19|
|End of Day Share Price||2021/04/19 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.